Randomized Controlled Trial

Citations 241-250 of 820 total displayed.

Past content (since Jan 1999):

Letters
Low-Fat Diet and Cardiovascular Disease—Reply

Barbara V. Howard; Garnet L. Anderson; Bette Caan; Judith Hsia; Karen Johnson; Marian Limacher; JoAnn E. Manson; Ross L. Prentice; Marcia L. Stefanick; Sylvia Wassertheil-Smoller; Linda Van Horn; for the Writing Groups for the WHI Investigators
JAMA 2006; 296: 280-a-281-a. [Extract] [Full text] [PDF]  

Letters
Low-Fat Diet and Cardiovascular Disease

Scott K. Aberegg; David T. Majure
JAMA 2006; 296: 280. [Extract] [Full text] [PDF]  

Medical News & Perspectives
Trials Probe New Agents for Kidney Cancer

Tracy Hampton
JAMA 2006; 296: 155-157. [Extract] [Full text] [PDF]  

Original Contributions
Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release Bupropion and Placebo for Smoking Cessation: A Randomized Controlled Trial

David Gonzales; Stephen I. Rennard; Mitchell Nides; Cheryl Oncken; Salomon Azoulay; Clare B. Billing; Eric J. Watsky; Jason Gong; Kathryn E. Williams; Karen R. Reeves; for the Varenicline Phase 3 Study Group
JAMA 2006; 296: 47-55. [Abstract] [Full text] [PDF] [ Author in the Room Audio ]  

Original Contributions
Efficacy of Varenicline, an 42 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion for Smoking Cessation: A Randomized Controlled Trial

Douglas E. Jorenby; J. Taylor Hays; Nancy A. Rigotti; Salomon Azoulay; Eric J. Watsky; Kathryn E. Williams; Clare B. Billing; Jason Gong; Karen R. Reeves; for the Varenicline Phase 3 Study Group
JAMA 2006; 296: 56-63. [Abstract] [Full text] [PDF]  

Original Contributions
Effect of Maintenance Therapy With Varenicline on Smoking Cessation: A Randomized Controlled Trial

Serena Tonstad; Philip Tønnesen; Peter Hajek; Kathryn E. Williams; Clare B. Billing; Karen R. Reeves; for the Varenicline Phase 3 Study Group
JAMA 2006; 296: 64-71. [Abstract] [Full text] [PDF]  

Original Contributions
Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily: A Randomized Controlled Trial

Paul B. Watkins; Neil Kaplowitz; John T. Slattery; Connie R. Colonese; Salvatore V. Colucci; Paul W. Stewart; Stephen C. Harris
JAMA 2006; 296: 87-93. [Abstract] [Full text] [PDF]  

Health Agencies Update
Breast Cancer Trial

Tracy Hampton
JAMA 2006; 295: 2839-b. [Extract] [Full text] [PDF]  

Letters
Incomplete Financial Disclosure for Study of Funding and Outcomes in Major Cardiovascular Trials

Paul M Ridker
JAMA 2006; 295: 2725-a-2726-a. [Extract] [Full text] [PDF]  

Original Contributions
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Victor G. Vogel; Joseph P. Costantino; D. Lawrence Wickerham; Walter M. Cronin; Reena S. Cecchini; James N. Atkins; Therese B. Bevers; Louis Fehrenbacher; Eduardo R. Pajon Jr; James L. Wade III; André Robidoux; Richard G. Margolese; Joan James; Scott M. Lippman; Carolyn D. Runowicz; Patricia A. Ganz; Steven E. Reis; Worta McCaskill-Stevens; Leslie G. Ford; V. Craig Jordan; Norman Wolmark; for the National Surgical Adjuvant Breast and Bowel Project (NSABP)
JAMA 2006; 295: 2727-2741. [Abstract] [Full text] [PDF] [ Author in the Room Audio ]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82